YOLFTbeta
Briacell Therapeutics Corp

Briacell Therapeutics Corp

BCTX · NASDAQ · Healthcare / Biotechnology

3.39USD-0.12 (-3.42%)

Price History

Full chart

Market Stats

Previous Close3.51
Open3.45
Day Range3.30 – 3.45
52-Week Range2.60 – 14.68
Volume25.19K
Market Cap37.24M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.90
Dividend Yield0.00%
Beta1.53
50-Day Avg3.66
200-Day Avg4.47

About

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate theclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. William V. Williams FCPA, M.D.
  • Employees0
  • HeadquartersBellevue Centre, West Vancouver, BC, Canada, V7T 2X1, USA
  • Websitehttps://briacell.com

Leadership

  • Dr. William V. Williams FCPA, M.D.CEO, President & Director · b. 1955
  • Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.CFO & Corporate Secretary · b. 1973
  • Dr. Miguel A. Lopez-Lago Ph.D.Chief Scientific Officer · b. 1970
  • Dr. Giuseppe Del Priore M.D., M.P.H.Chief Medical Officer · b. 1962
  • Dr. Charles Louis Wiseman FACP, M.D.Founder, Principal Research Advisor & Member of Scientific Advisory Board · b. 1947

Financials

Income Statement

Currency: USD2006-07-312007-07-312008-07-312009-07-312010-07-312011-07-312012-07-312013-07-312014-07-312015-07-312016-07-312017-07-312018-07-312019-07-312020-07-312021-07-312022-07-312023-07-312024-07-312025-07-31
Total Revenue------------0000000-
Cost of Revenue---165.6743.57K55.93K72.26K-80.34K61.24K565.351.80K289.7116.88K18.83K18.73K15.58K15.14K15.53K82.57K147.89K
Gross Profit----165-43.57K-55.93K-72.26K80.34K-61.24K-565-1.80K-289-16.88K-18.83K-18.73K-15.58K-15.14K-15.53K-82.57K-147.89K
Operating Expense---251.10K290.71K946.35K487.35K370.46K415.23K1.87M2.19M3.21M4.96M6.23M5.26M8.70M19.59M31.07M33.26M37.58M
Operating Income-8.58K-129.06K-114.12K-251.27K-334.28K-1.00M-559.62K-290.12K-476.47K-1.88M-2.19M-3.21M-4.97M-6.25M-5.28M-8.72M-19.61M-31.08M-33.34M-37.73M
EBITDA-9.71K-123.96K-101.40K-245.66K-926.36K-1.02M-997.25K-381.57K-8.89M-3.49M-2.23M-3.22M-5.37M-5.77M-4.82M-17.15M-34.40M-31.06M-4.85M-37.58M
Net Income-8.58K-116.41K-98.93K-245.83K-927.69K-1.03M-998.99K-381.98K-8.90M-3.49M-2.23M-3.22M-5.41M-5.82M-4.94M-17.27M-34.42M-27.11M-4.79M-36.49M
R&D---------137.75K952.15K2.12M3.11M4.94M2.98M2.53M10.29M20.48M27.19M29.50M
Interest Expense0002.73K2.90K13.36K38.01K16.90K12.00K7.09K3.63K5.16K20.34K31.47K36.20K100.22K1.24K0-51.29K

Balance Sheet

Currency: USD2006-07-312007-07-312008-07-312009-07-312010-07-312011-07-312012-07-312013-07-312014-07-312015-07-312016-07-312017-07-312018-07-312019-07-312020-07-312021-07-312022-07-312023-07-312024-07-312025-07-31
Total Assets96.35K456.29K380.81K1.04M1.47M12.35M10.32M9.41M23.91K1.28M835.70K1.64M2.28M444.66K522.33K72.54M54.60M36.28M8.15M29.77M
Total Liabilities16.54K9.58K15.64K64.19K29.15K716.66K283.94K74.46K25.04K117.17K48.59K885.90K1.34M1.13M4.12M37.96M41.36M41.32M11.88M5.93M
Total Equity79.82K446.71K365.17K974.50K1.44M11.63M10.03M9.33M-1.13K1.16M787.11K750.23K945.02K-688.66K-3.60M34.58M13.25M-5.04M-3.31M24.58M
Cash88.40K445.43K350.58K761.68K1.37M3.95M1.50M966.53K23.90K357.23K131.58K1.01M720.26K157.03K21.25K71.57M52.63M28.38M1.20M14.43M
Total Debt------------1.12M322.53K249.80K32.48K----
Net Debt-88.40K-445.43K-350.58K-761.68K-1.37M-3.95M-1.50M-966.53K-23.90K-357.23K-131.58K-1.01M400.40K165.49K228.55K-71.54M-52.63M-28.38M-1.20M-14.43M

Cash Flow

Currency: USD2006-07-312007-07-312008-07-312009-07-312010-07-312011-07-312012-07-312013-07-312014-07-312015-07-312016-07-312017-07-312018-07-312019-07-312020-07-312021-07-312022-07-312023-07-312024-07-312025-07-31
Operating Cash Flow1.13K-87.76K-89.68K-151.05K-318.63K-656.68K-382.74K-381.80K-397.42K-1.19M-1.58M-1.91M-4.95M-5.12M-1.55M-9.89M-15.87M-31.89M-32.97M-39.07M
Investing Cash Flow---25.42K-167.11K-441.75K-3.39M-1.91M-129.95K280.78K-411.62K208.98K149.85K-590.50K1.35M0----931.67K-10.61M
Financing Cash Flow88.40K439.28K-777.88K1.35M6.40M25.04K-1.75M2.07M1.06M2.89M5.29M3.01M1.44M82.92M-4.76M5.31M6.04M63.04M
Capital Expenditure0089.68K167.11K496.09K2.24M2.52M457.68K157.51K2.26K3.02435.0204.2703.59624.21K3.08
Free Cash Flow1.13K-87.76K-87.41K-318.16K-814.72K-2.89M-2.90M-839.48K-554.93K-1.19M-1.58M-1.91M-4.95M-5.12M-1.55M-9.89M-15.87M-31.89M-33.59M-39.07M
FCF to OCF100.00%100.00%97.46%210.63%255.69%440.74%757.80%219.87%139.63%100.19%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%101.89%100.00%

Earnings

Report DateApr 30, 2012Jul 31, 2012Oct 31, 2012Jan 31, 2013Apr 30, 2013Jul 31, 2013Oct 31, 2013Jan 31, 2014Apr 30, 2014Jul 31, 2014Oct 31, 2014Jan 31, 2015Apr 30, 2015Jul 31, 2015Oct 31, 2015Jan 31, 2016Apr 30, 2016Jul 31, 2016Oct 31, 2016Jan 31, 2017Apr 30, 2017Jul 31, 2017Oct 31, 2017Jan 31, 2018Apr 30, 2018Jul 31, 2018Oct 31, 2018Jan 31, 2019Apr 30, 2019Jul 31, 2019Oct 31, 2019Jan 31, 2020Apr 30, 2020Jul 31, 2020Oct 31, 2020Jan 31, 2021Apr 30, 2021Dec 15, 2021Mar 14, 2022Jun 13, 2022Oct 27, 2022Dec 14, 2022Mar 15, 2023Jun 14, 2023Oct 25, 2023Dec 14, 2023Mar 18, 2024Jun 14, 2024Oct 23, 2024Dec 16, 2024Mar 12, 2025Jun 16, 2025Oct 15, 2025Dec 12, 2025Mar 11, 2026Jun 10, 2026Oct 21, 2026
EPS Estimate---------------------------------------24.75-31.50-0.35-49.50-53.25-53.25-0.39-27.00-30.00-82.50-0.46-12.00-1.94-17.60-12.11----
EPS Actual-942.42-1269.28-202.78-218.38-280.25-256.95-389.91-211.05-1356.23-18909.98-302.16-1683.74-197.91-180.57-162.66-386.29-169.89-147.13-163.55-139.93-387.91-382.27-207.67-309.40-464.88-465.55-225.64-328.33-281.08-292.34-1.82-297.18-105.79-105.72-71.24-43.7191.03-0.16-36.00-48.00-1.02-10.50-115.50-48.00-0.1554.00-106.5016.50-0.07-33.00-2.33-16.400.04-4.35-2.58-0.99-
Surprise---------------------------------------45.45%-52.38%-191.43%78.79%-116.90%9.86%61.54%300.00%-255.00%120.00%84.78%-175.00%-20.10%6.82%100.33%----
Timing-------------------------------------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours----

Key Statistics & Ratios

Market Cap37.24M
Enterprise Value12.78M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book1.49
EPS-0.90
Book Value3.32
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-31.92M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-175.26%
Return on Assets-90.84%
Shares Outstanding8.70M
Shares Float7.86M
Beta1.53
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 2 analystsTarget 150.00
  • Strong Buy
    1
  • Buy
    1

Ownership Breakdown

Institutions
6.39%
Insiders
0.51%
Retail / Other
93.10%

Top Institutional Holders

  • Cable Car Capital LLC
    216.82K2.49%
  • Sabby Management LLC
    73.92K0.85%
  • Iridian Asset Management LLC
    65.00K0.75%
  • LuminArx Capital Management LP
    15.00K0.17%
  • UBS Group AG
    11.54K0.13%
  • Morgan Stanley - Brokerage Accounts
    3.02K0.03%
  • NATIONAL BANK OF CANADA /FI/
    1.80K0.02%
  • Federation des caisses Desjardins du Quebec
    4550.01%
  • Hanson Mcclain Inc
    1000.00%
  • Royal Bank of Canada
    1000.00%
  • SSA SWISS ADVISORS AG
    370.00%
  • TD Waterhouse Canada Inc
    190.00%
  • Group One Trading, LLC
    160.00%
  • Caitong International Asset Management Co., Limited.
    70.00%
  • HHM Wealth Advisors, LLC
    60.00%
  • Wells Fargo & Co
    10.00%
  • Tower Research Capital LLC
    00.00%
  • FLAGSHIP HARBOR ADVISORS, LLC
    00.00%

Top Fund Holders

  • Fidelity Nasdaq Composite Index
    3.23K0.04%

Stock Splits

  • Aug 25, 20251:10
  • Jan 29, 20251:15
  • Jan 2, 20201:300
  • Dec 3, 20144:13